Solventum

Methodology

Solventum's healthcare business spun from 3M includes infection prevention, dental, and health information systems creating relatively predictable earnings. The calculation becomes more applicable as the standalone company establishes its track record. Evaluate normalized profitability without 3M legacy costs and assess each business segment's growth trajectory separately.

Methodology

Solventum's PEG ratio reflects the newly independent company's positioning in healthcare markets with varying growth profiles. The metric should account for operational improvements from independence and separation from 3M's challenges. Compare to diversified med-tech and dental companies while considering Solventum's portfolio mix and margin opportunity.

Methodology

Solventum's dividend policy as an independent company balances capital returns with debt reduction and strategic flexibility. The dividend adds some value though investors focus more on operational execution. For this newly spun healthcare company, proving standalone value creation matters more than traditional income metrics initially.